Abstract:[Objective] To explore the significance of retinol binding protein-4 (RBP4) for diagnosis of nontraumatic osteonecrosis of fem- oral head (NONFH) . [Methods] A total of 70 patients who were diagnosed of NONFH in Department of Hip Surgery, People's Hospital of Linyi City from August 2021 to December 2021 were selected as the necrosis group, while other 62 healthy subjects matched in age with the necrosis group in the same period were selected as the normal group. The serum RBP4 concentration of the two groups of subjects was detected by en- zyme-linked immunosorbent assay. The general data of the two groups were compared. The serum RBP4 level in the necrosis group was com- pared according to different factors, including etiology, ARCO stage, unilateral or bilateral hips involved and the femoral head uncollapsed or collapsed. The correlations between RBP4 and clinical parameters were searched, and ROC curve was drawn to analyze the diagnostic value of serum RBP4 for NONFH. [Results] The level of serum RBP4 in the necrotic group was significantly lower than that in the normal group (P< 0.05) . In the necrosis group, the level of serum RBP4 was significantly lower in patients with femoral head collapse than that in those without femoral head collapse (P<0.05) , significantly lower in the patients with bilateral femoral head involved than in those with unilateral necrosis (P<0.05) . There were significant differences in serum RBP4 levels among different ARCO stages (P<0.05) , the higher stage the lower serum RBP4. In terms of correlation analysis, serum RBP4 level was negatively correlated with VAS score and ARCO stage (P<0.05) , while was weakly positively correlated with Harris score (P<0.05) . In term of ROC analysis, serum RBP4 level was used for diagnosis of femoral head ne- crosis and collapse with the sensitivity of 64.3%, specificity of 96.8% and area under curve (AUC) of 0.895. [Conclusion] As progress of NONFH, the serum RBP4 is prone to decline. Therefore, the serum RBP4 is a potential serum marker for the diagnosis of NONFH.